Health Condition 1: N461- Oligospermia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male patients in the age group of 21-50 years 2. People belonging to all socio-economic groups 3. Sperm count at or below 15 million/millilitre
Exclusion criteria
Exclusion criteria: 1. Patients taking allopathic and other treatments for infertility 2. patients under immunosuppressive medications 3. Patients with azoospermia and aspermia 4. Patients with genetic defects like Klinefelter s syndrome and congenital abnormalities 5. Patients with diseases like accessory sex gland infection, and sexually transmitted diseases 6. Patients with obstructive oligospermia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. IN SILICO STUDY TITLE: Action of zinc molecule in zincum metallicum on target protein of spermatogenesis through in silico study DESCRIPTION:identification of zinc molecule in zincum metallicum on target protein with more binding energy. Interval:1 month 2. CLINICAL STUDY TITLE: Change in the semen analysis. DESCRIPTION: Semen analysis baseline value Final semen analysis INTERVAL:3 monthsTimepoint: Aftermedicinal prescription according to homoeopathic principle semen analysis will be repeated ater 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of Therapeutic effectiveness of Zincum metallicum & constitutional medicine among the group Timepoint: After 1 Year (after completion of the study) | — |
Countries
India
Contacts
Government Homoeopathic Medical College Kozhikode